As of Oct 24
| 0.00 / 0.00%|
The 23 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 465.00, with a high estimate of 633.00 and a low estimate of 325.00. The median estimate represents a +28.36% increase from the last price of 362.25.
The current consensus among 27 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since October, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.